DEE55
MCID: DVL079
MIFTS: 25
|
Developmental and Epileptic Encephalopathy 55 (DEE55)
Categories:
Cancer diseases, Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Respiratory diseases
|
|
MalaCards integrated aliases for Developmental and Epileptic Encephalopathy 55:
Characteristics:OMIM®:57 (Updated 05-Mar-2021)
Inheritance:
autosomal recessive
Miscellaneous:
onset in infancy death in childhood may occur three unrelated families have been reported (last curated march 2020) HPO:31
developmental and epileptic encephalopathy 55:
Inheritance autosomal recessive inheritance Onset and clinical course infantile onset neonatal onset Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Fetal diseases Cancer diseases Anatomical: Neuronal diseases Eye diseases Liver diseases Ear diseases Respiratory diseases Mental diseases |
OMIM® :
57
Developmental and epileptic encephalopathy-55 (DEE55) is an autosomal recessive neurologic disorder characterized by onset of refractory seizures in the first weeks or months of life. Affected individuals have an extremely poor outcome, with profoundly impaired intellectual development, absent speech, spastic quadriplegia, and dyskinetic movements. Most have cortical visual impairment and require a feeding tube. Brain imaging shows nonspecific abnormalities, including cerebral atrophy, thin corpus callosum, and abnormal signals in the white matter. Death in childhood may occur. Biochemically, the disorder is associated with impaired synthesis of GPI-anchored proteins (summary by Vetro et al., 2020).
For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
For a discussion of genetic heterogeneity of GPI biosynthesis defects, see GPIBD1 (610293). (617599) (Updated 05-Mar-2021)
MalaCards based summary : Developmental and Epileptic Encephalopathy 55, is also known as glycosylphosphatidylinositol biosynthesis defect 14. An important gene associated with Developmental and Epileptic Encephalopathy 55 is PIGP (Phosphatidylinositol Glycan Anchor Biosynthesis Class P). Affiliated tissues include eye, and related phenotypes are clonus and global developmental delay Disease Ontology : 12 A developmental and epileptic encephalopathy characterized by onset in the first weeks or months of life of refractory seizures, profoundly impaired intellectual development, absent speech, spastic quadriplegia, and dyskinetic movements that has material basis in homozygous or compound heterozygous mutation in the PIGP gene on chromosome 21q22. UniProtKB/Swiss-Prot : 73 Epileptic encephalopathy, early infantile, 55: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE55 is an autosomal recessive condition. |
Human phenotypes related to Developmental and Epileptic Encephalopathy 55:31 (show all 22)
Symptoms via clinical synopsis from OMIM®:57 (Updated 05-Mar-2021)Clinical features from OMIM®:617599 (Updated 05-Mar-2021) |
|
MalaCards organs/tissues related to Developmental and Epileptic Encephalopathy 55:40
Eye
|
Articles related to Developmental and Epileptic Encephalopathy 55:
|
ClinVar genetic disease variations for Developmental and Epileptic Encephalopathy 55:6
UniProtKB/Swiss-Prot genetic disease variations for Developmental and Epileptic Encephalopathy 55:73
|
Search
GEO
for disease gene expression data for Developmental and Epileptic Encephalopathy 55.
|
|
|